COMMUNIQUÉS West-GlobeNewswire

Intuitive Announces Board of Directors Elections and Retirements

26/04/2024 - 01:15

Lewis Chew elected to Intuitive’s Board Alan Levy, PhD and Don Kania, PhD to retire from Board SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally [...]

Altimmune Statement on the Passing of Dr. Stephen Harrison

25/04/2024 - 23:24

GAITHERSBURG, Md., April 25, 2024 (GLOBE NEWSWIRE) -- The Altimmune team would like to express our sorrow and extend our heartfelt condolences to Dr. Stephen Harrison’s family following his tragic and unexpected passing [...]

Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing

25/04/2024 - 22:55

Shenzhen, China, April 25, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today [...]

Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024

25/04/2024 - 22:46

COPENHAGEN, Denmark, April 25, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2024 financial results and provide a business update on Thursday, May 2, 2024, [...]

Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World

25/04/2024 - 22:33

10 Barrel Brewing Wins Innovation in Craft Brewing Award and Sweeps German-Style Sour Ale Category with Gold, Silver, and Bronze Medals Green Flash Brewing Wins Bronze in Juicy or Hazy Pale Ale Category NEW YORK, April [...]

Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update

25/04/2024 - 22:30

NOVATO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and [...]

Combined General Meeting of May 16, 2024

25/04/2024 - 22:30

Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: [...]

Assemblée Générale Mixte du 16 mai 2024

25/04/2024 - 22:30

Châtillon, France, le 25 avril 2024 Assemblée Générale Mixte du 16 mai 2024 Modalités de mise à disposition des informations et documents préparatoires à l’Assemblée Générale Mixte DBV Technologies (Euronext : DBV – [...]

Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024

25/04/2024 - 22:15

TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. [...]

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update

25/04/2024 - 22:15

ARCA biopharma and Oruka Therapeutics announce Merger Agreement ARCA biopharma appoints Thomas Keuer as President WESTMINSTER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company [...]

GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)

25/04/2024 - 22:10

Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company committed to improving the lives of patients with rare, [...]

GENFIT : Publication du rapport de performance extra-financière 2024 (exercice 2023)

25/04/2024 - 22:10

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 25 avril 2024 – GENFIT (Nasdaq et Euronext: GNFT) , société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]

Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024

25/04/2024 - 22:05

CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational [...]

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update

25/04/2024 - 22:05

- Management will hold a conference call on Thursday, May 2 at 4:30 p.m. ET/1:30 p.m. PT - SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company [...]

Y-mAbs to Present at 2024 ASCO Annual Meeting

25/04/2024 - 22:05

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel [...]

IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd

25/04/2024 - 22:05

WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, [...]

Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting

25/04/2024 - 22:05

REDWOOD CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular [...]

Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study

25/04/2024 - 22:05

Data demonstrates a 7-day treatment regimen with the pan-coronavirus protease inhibitor ALG-097558 was well tolerated and does not require ritonavir boosting SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE [...]

NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

25/04/2024 - 22:05

In vitro studies with SNK01 have shown a direct ability to phagocytose and digest amyloid and alpha-synuclein proteins while also secreting immunoregulatory cytokines and identifying and eliminating autoreactive T cells [...]